Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Drug Dev Ind Pharm. 2016 Aug 21;43(5):789–796. doi: 10.1080/03639045.2016.1220567

Table 5.

Drug content analysis for the compatibility study of F1 b (10% LNS- 30% F68- K12) and F2 (10% LNS- 4% MgO- 30% F68- K12) mixed with the enteric coating polymer L100-55 in a ratio of 1:2 after 6 and 12 months of storage (25°C/60% RH)

Mixture Duration of the sorage (months) Drug content (%)
F1 b + Eudragit® L100-55 6 9.3 ± 1.2
F1 b + Eudragit® L100-55 12 0
F2 + Eudragit® L100-55 6 97 ± 2.3
F2 + Eudragit® L100-55 12 97 ± 5.1

(mean ± SD, n = 3)